Evidence map›Paper›PMID 41053455›Full record

ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2025

Association of preoperative risk factors with therapeutic outcomes in primary hyperparathyroidism: A multivariate analysis of imaging and PTH-Calcium-Phosphate metabolic parameters in 164 cases.

Nuan Li, Zishi Huang, Junwei Huang, Wei Guo, Xiaohong Chen, Qi Zhong, Jugao Fang, Yang Zhang, Zhigang Huang

Abstract read
PubMed Publisher
In one paragraph

Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nuan Li *Beijing Tongren Hospital, Capital Medical University, Beijing, China.ORCID http://orcid.org/0000-0002-5006-1069
Zishi Huang *Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Junwei HuangBeijing Tongren Hospital, Capital Medical University, Beijing, China.
Wei GuoBeijing Tongren Hospital, Capital Medical University, Beijing, China.
Xiaohong ChenBeijing Tongren Hospital, Capital Medical University, Beijing, China.
Qi ZhongBeijing Tongren Hospital, Capital Medical University, Beijing, China.
Jugao FangBeijing Tongren Hospital, Capital Medical University, Beijing, China.
Yang ZhangBeijing Tongren Hospital, Capital Medical University, Beijing, China. entzhangyang@163.com.
Zhigang HuangBeijing Tongren Hospital, Capital Medical University, Beijing, China. enthuangzhigang@sohu.com.ORCID http://orcid.org/0009-0008-4174-3229

Funding

National Natural Science Foundation of China 82271150National Natural Science Foundation of China 82371128
6 · The paper itself

Abstract

objectiveThis study aimed to identify independent risk factors associated with pathological subtypes, disease progression, and adverse outcomes in Primary hyperparathyroidism (PHPT) by analyzing clinical characteristics, thereby informing individualized therapeutic strategies.

methodsA retrospective analysis was conducted on 164 PHPT patients treated at Beijing Tongren Hospital from May 2009 to December 2024. The analysis encompassed demographic data, preoperative evaluations, surgical details, histopathological reports, and postoperative metabolic parameters.

resultsPHPT predominantly affected females, with 84.1% of cases diagnosed incidentally during routine examinations. Preoperative ultrasonography and radionuclide imaging demonstrated high diagnostic accuracy for lesion localization (97.4% and 75.4%, respectively). Parathyroidectomy effectively normalized serum calcium, Phosphate, and parathyroid hormone (PTH) levels (P < .001). However, delayed postoperative PTH recovery correlated with advanced age (P = .038), elevated preoperative PTH and calcium levels (P < .001), and larger lesion size (> 3 cm, P < .001). Among patients with preoperative hypercalcemia, male sex (p = .039) and relatively lower baseline serum calcium levels (p = .004), combined with baseline hypophosphatemia (p = .013), were associated with an increased risk of transient or permanent postoperative hypoparathyroidism. Benign solitary adenomas showed an 8.695-fold higher treatment efficacy than malignant lesions. Preoperative phosphate levels (P = .037) and lesion size (P = .037) emerged as discriminative predictors for pathological subtypes, while severe preoperative hypophosphatemia independently indicated poor therapeutic outcomes. Smaller lesions correlated with better postoperative calcium-phosphate recovery, whereas preoperative hypercalcemia and larger lesion volume significantly influenced PTH improvement magnitude (P < .001).

conclusionOur findings affirmed parathyroidectomy's central role in PHPT management, highlighting substantial differences in treatment responses between benign and malignant cases. The study establishes a clinical decision-making framework combining preoperative imaging volumetry with serum PTH-calcium-phosphate profiling, enhancing pathological differentiation, guiding surgical planning, and predicting postoperative recovery trajectories. These insights enable more tailored therapeutic approaches, though validation through multicenter prospective studies remains essential for refining prognostic models and optimizing treatment protocols.

Indexed as

CalciumHyperparathyroidism, PrimaryParathyroidectomyParathyroid HormonePhosphatesAdultAgedFemaleHumansMaleMiddle AgedMultivariate AnalysisRetrospective StudiesRisk FactorsTreatment OutcomeUltrasonographyCalciumParathyroid HormonePhosphatesAssessment of efficacyDisease characteristicsParathyroid hormonePrimary hyperparathyroidismPrognostic model

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.